Eric Florence
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
AdMiRE study: Development and validation of a WHO-aligned tool to assess healthcare access and antibiotic use among migrant populations in Europe-a multicountry Delphi and psychometric study on behalf of ESGITM group.
Journal: CMI communications
Published: December 08, 2025
Epidemiological, clinical, and biological profiles of People Living With HIV in the PMTCT department of Panzi hospital: a retrospective cohort study in Eastern DR. Congo.
Journal: AIDS research and therapy
Published: April 01, 2025
Correction for Van Gulck et al., "A truncated HIV Tat demonstrates potent and specific latency reversal activity".
Journal: Antimicrobial agents and chemotherapy
Published: July 02, 2024
Integrase Strand Transfer Inhibitor-Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 03, 2024
Rhodococcus equi, an Unusual Human Pathogen That Causes Cavitating Pneumonia in Patients With AIDS.
Journal: Case reports in infectious diseases
Published: March 06, 2024
Assessing the Effectiveness of an mHealth Intervention to Support Men Who Have Sex With Men Engaging in Chemsex (Budd): Single-Case and Pre-Post Experimental Design Study.
Journal: JMIR formative research
Published: January 22, 2024
Pre-exposure prophylaxis (PrEP) use trajectories and incidence of HIV and other sexually transmitted infections among PrEP users in Belgium: a cohort analysis of insurance claims data from 2017 to 2019.
Journal: BMC public health
Published: January 11, 2024
Uptake and challenges with daily oral pre-exposure prophylaxis among men who have sex with men and transgender women, suburban Yangon, Myanmar.
Journal: International health
Published: November 21, 2023
Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical Settings.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: October 31, 2023
A truncated HIV Tat demonstrates potent and specific latency reversal activity.
Journal: Antimicrobial agents and chemotherapy
Published: October 24, 2023
Failure of artemether-lumefantrine therapy in travellers returning to Belgium with Plasmodium falciparum malaria: an observational case series with genomic analysis.
Journal: Journal of travel medicine
Published: October 23, 2023
Last Updated: 09/26/2026